- Home
- TRVI vs BGM Comparison
TRVI vs BGM Comparison
Compare TRVI & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- BGM
- Stock Information
- Founded
- TRVI 2011
- BGM 2019
- Country
- TRVI United States
- BGM China
- Employees
- TRVI N/A
- BGM N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- TRVI Health Care
- BGM
- Exchange
- TRVI Nasdaq
- BGM NYSE
- Market Cap
- TRVI 383.4M
- BGM 962.5M
- IPO Year
- TRVI 2019
- BGM 2021
- Fundamental
- Price
- TRVI $6.14
- BGM $9.80
- Analyst Decision
- TRVI Strong Buy
- BGM
- Analyst Count
- TRVI 8
- BGM 0
- Target Price
- TRVI $15.94
- BGM N/A
- AVG Volume (30 Days)
- TRVI 4.1M
- BGM 8.1K
- Earning Date
- TRVI 05-06-2025
- BGM 03-25-2025
- Dividend Yield
- TRVI N/A
- BGM N/A
- EPS Growth
- TRVI N/A
- BGM N/A
- EPS
- TRVI N/A
- BGM N/A
- Revenue
- TRVI N/A
- BGM $25,097,951.00
- Revenue This Year
- TRVI N/A
- BGM N/A
- Revenue Next Year
- TRVI N/A
- BGM N/A
- P/E Ratio
- TRVI N/A
- BGM N/A
- Revenue Growth
- TRVI N/A
- BGM N/A
- 52 Week Low
- TRVI $2.30
- BGM $2.61
- 52 Week High
- TRVI $7.39
- BGM $14.78
- Technical
- Relative Strength Index (RSI)
- TRVI 77.07
- BGM 52.46
- Support Level
- TRVI $4.24
- BGM $9.51
- Resistance Level
- TRVI $7.39
- BGM $11.33
- Average True Range (ATR)
- TRVI 0.49
- BGM 0.54
- MACD
- TRVI 0.20
- BGM 0.03
- Stochastic Oscillator
- TRVI 65.45
- BGM 58.38
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.